Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Apply
H5N8 Vaccine
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step